Journal articleAnn Pancreat Cancer2019
Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma.
- Journal
- Ann Pancreat Cancer
- Published
- 1 December 2019
- Citations
- 11
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- Cancer Prevention and Control Program P30CA006973↗
- Core 2: Biospecimen/Pathology Core P50CA062924↗
- Interrogate the interaction between tumor cells and nerves in the tumor microenvironment of pancreatic cancer R01CA169702↗
- Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial R01CA197296↗